FDA allows Houston cancer doctor to resume drug trial

Federal regulators have lifted a partial hold on a clinical trial performed by Stanislaw

FDA issues warning to controversial Houston cancer doctor

Doctor claims to cure pediatric cancer, critics skeptical

Vaccines, Free Full-Text

Clinical Research Project Manager - CCRPS

Katy Rezvani MD Anderson Cancer Center

Fast-Track Drug Approval, Designed for Emergencies, Is Now Routine - WSJ

Houston doctor discovers way to treat pancreatic cancer during clinical trial

Elias Jabbour MD Anderson Cancer Center

Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial - The Lancet Oncology